Lyso-Gb1 as a biomarker of treatment outcomes in Gaucher disease: An evaluation of data from the Gaucher Outcome Survey (GOS) registry
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI